Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fidelity Spartan® Extended Market Index Fund Investor Class (FSEMX)

Net Asset Value
1 Day
Overall Morningstar Rating
Mid-cap blend
Style or Category
No Load
Sales Expenses
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks to provide investment results that correspond to the total return of stocks of mid- to small-capitalization United States companies. The fund normally invests at least 80% of assets in common stocks included in the Dow Jones U.S. Completion Total Stock Market IndexSM, which represents the performance of stocks of mid- to small-capitalization U.S. companies. It uses statistical sampling techniques based on such factors as capitalization, industry exposures, dividend yield, price/earnings (P/E) ratio, price/book (P/B) ratio, and earnings growth to attempt to replicate the returns of the index using a smaller number of securities.


1 month+2.26% 3 years+8.63%
3 months+10.53% 5 years+8.18%
1 year-7.42% Since inception+7.27%
Data through --

Peer Comparisonvs. Mid-cap blend

Performance 5-yr return+8.18%+7.75%
Expense ratio0.10%1.18%
Risk 5 year sharpe ratio0.600.59
Net assets$15.5B$1.6B
Average market cap$3.1B$6.7B
Average P/E18.418.1
Portfolio turnover12%12%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyFidelity Investments
Fund manager & tenurePatrick Waddell / 12 Years
Minimal initial investment$2,500.00
Minimum IRA investment$2,500.00


U.S. stock97.52%
International stock1.76%
Fixed income0.09%
Top 5 Sectors
Portfolio weighting
Financial service 20.22%
Industrial materials 14.90%
Healthcare 10.49%
Consumer service 8.72%
Consumer goods 8.30%
Top 10 Holdings
Portfolio weighting
LBTYK Liberty Global PLC0.59%
TSLA Tesla0.52%
-- 0.48%
LVS Las Vegas Sands Corp0.47%
CHTR Charter Communications Inc0.36%
LNKD LinkedIn0.36%
BMRN Biomarin Pharmaceutical Inc0.35%
INCY Incyte Corp0.33%
-- 0.32%
MKL Markel Corp0.32%

Partner Offers